first reported DTCs when treating epidermal growth factor receptor mutant non-small cell lung cancer PC9 cells with the tyrosine kinase inhibitor erlotinib induced the formation of DTCs after removing the drug. Here, EGFR is linked to non-small cell lung carcinoma.